Cardiology
News
ICMs detect serious arrhythmias in high-risk post-MI patients: SMART-MI
In patients with modestly reduced left ventricular ejection fraction after MI, implantable monitors detect many times more arrhythmias than usual...
Clinical
Optimizing screening for asymptomatic Afib
How can we optimize screening for patients with asymptomatic atrial fibrillation (Afib)?
News
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthrough
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection...
Clinical
ACE-I or ARB therapy in patients with low eGFR
Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose...
News
SGLT2 inhibitor use rising in patients with DKD
Clinical
Apixaban more effective, safer than rivaroxaban for Afib patients
Is apixaban more effective and safer than rivaroxaban in patients with atrial fibrillation?
News
Empagliflozin gets HFrEF approval from FDA
The SGLT2 inhibitor empagliflozin (Jardiance) becomes the second agent from this class to get a heart failure indication regardless of diabetes...
Clinical
Use of point-of-care ultrasound (POCUS) for heart failure
Hospitalist use of POCUS may include guiding procedures, aiding in diagnosis, and assessing effectiveness of treatment.
News
Heparin’s COVID-19 benefit greatest in moderately ill patients
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients...
News
Tachycardia syndrome may be distinct marker for long COVID
Post-COVID patients with palpitations or chest pain should undergo a cardiac workup, new research suggests. The data also shed light on potential...